Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812

Status:

Topic selection

Technology type:

Medicine

Decision:

Selected

ID number:

11812

Project Team

Project lead

[email protected]

Email enquiries

If you have any queries please email [email protected]

For further information on how we select topics for development, please see our page about prioritising our guidance topics